These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonists. Saito T; Obitsu T; Minamoto C; Sugiura T; Matsumura N; Ueno S; Kishi A; Katsumata S; Nakai H; Toda M Bioorg Med Chem; 2011 Oct; 19(20):5955-66. PubMed ID: 21930387 [TBL] [Abstract][Full Text] [Related]
35. Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety. St-Denis Y; Di Fabio R; Bernasconi G; Castiglioni E; Contini S; Donati D; Fazzolari E; Gentile G; Ghirlanda D; Marchionni C; Messina F; Micheli F; Pavone F; Pasquarello A; Sabbatini FM; Zampori MG; Arban R; Vitulli G Bioorg Med Chem Lett; 2005 Aug; 15(16):3713-6. PubMed ID: 15946843 [TBL] [Abstract][Full Text] [Related]
36. New class of corticotropin-releasing factor (CRF) antagonists: small peptides having high binding affinity for CRF receptor. Yamada Y; Mizutani K; Mizusawa Y; Hantani Y; Tanaka M; Tanaka Y; Tomimoto M; Sugawara M; Imai N; Yamada H; Okajima N; Haruta J J Med Chem; 2004 Feb; 47(5):1075-8. PubMed ID: 14971886 [TBL] [Abstract][Full Text] [Related]
37. Binding kinetics redefine the antagonist pharmacology of the corticotropin-releasing factor type 1 receptor. Fleck BA; Hoare SR; Pick RR; Bradbury MJ; Grigoriadis DE J Pharmacol Exp Ther; 2012 May; 341(2):518-31. PubMed ID: 22357972 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonists. Ahuja VT; Hartz RA; Molski TF; Mattson GK; Lentz KA; Grace JE; Lodge NJ; Bronson JJ; Macor JE Bioorg Med Chem Lett; 2016 May; 26(9):2184-7. PubMed ID: 27020524 [TBL] [Abstract][Full Text] [Related]